<SEC-DOCUMENT>0001326110-25-000084.txt : 20250620
<SEC-HEADER>0001326110-25-000084.hdr.sgml : 20250620
<ACCEPTANCE-DATETIME>20250620163924
ACCESSION NUMBER:		0001326110-25-000084
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250618
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250620
DATE AS OF CHANGE:		20250620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ImmunityBio, Inc.
		CENTRAL INDEX KEY:			0001326110
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				431979754
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37507
		FILM NUMBER:		251061996

	BUSINESS ADDRESS:	
		STREET 1:		3530 JOHN HOPKINS COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(844) 696-5235

	MAIL ADDRESS:	
		STREET 1:		3530 JOHN HOPKINS COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NantKwest, Inc.
		DATE OF NAME CHANGE:	20150713

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Conkwest, Inc.
		DATE OF NAME CHANGE:	20140416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZelleRx Corp
		DATE OF NAME CHANGE:	20050504
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ibrx-20250618.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13d9eae9-a91a-4090-bf8c-9b7bc7debb08,g:5c9f2723-5c82-43d2-9f98-d449f80a92e6,d:e1025dff6a3c47129b1c8e38a5bfd26e-->
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ibrx-20250618</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001326110</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ibrx-20250618.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-18</xbrli:startDate><xbrli:endDate>2025-06-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie1025dff6a3c47129b1c8e38a5bfd26e_1"></div><div style="min-height:13.5pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">June&#160;18,&#160;2025</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">ImmunityBio, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:31.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.754%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37507</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">43-1979754</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3530 John Hopkins Court</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92121</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">(844)</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">696-5235</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction&#160;A.2. below):</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.635%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">on which registered</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">IBRX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of&#160;1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie1025dff6a3c47129b1c8e38a5bfd26e_102"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02 &#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of ImmunityBio, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) previously approved, subject to stockholder approval, the Company&#8217;s 2025&#160;Equity Incentive Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025&#160;Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). At the 2025&#160;Annual Meeting of Stockholders on <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-23">June&#160;18,&#160;2025</ix:nonNumeric> (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Meeting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Company&#8217;s stockholders approved the 2025&#160;Plan, which became effective upon stockholder approval. As of such date, the 2025&#160;Plan replaced the Company&#8217;s 2015&#160;Equity Incentive Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2015&#160;Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in its entirety, which was scheduled to expire in July&#160;2025. No further awards will be made under the 2015&#160;Plan, but the 2015&#160;Plan will continue to govern awards previously granted under it.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board approved and recommended the 2025&#160;Plan in order to effectively compete for and appropriately motivate and reward key talent through grants of equity-based awards. The Board believed it to be in the long-term interest of both the Company and its stockholders to strengthen the Company&#8217;s ability to attract, retain and motivate employees, officers, non-employee directors and certain other service providers and to provide additional incentive for those persons through stock ownership and other incentives to improve financial performance, increase profits and strengthen the mutuality of interest between those persons and the Company&#8217;s stockholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the adjustment provisions of the 2025&#160;Plan, the number of shares of common stock reserved for issuance under the 2025&#160;Plan is: (i)&#160;46,088,027&#160;shares of common stock, plus (ii)&#160;up to 32,359,674&#160;shares subject to awards granted under the 2015&#160;Plan that, on or after the date of stockholder approval of the 2025&#160;Plan, expire or terminate without having been exercised in full, are tendered to or withheld for payment of an exercise price or for tax withholding obligations, or are forfeited or repurchased due to failure to vest.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material terms of the 2025&#160;Plan are described in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal&#160;2 &#8211; Approval of the ImmunityBio, Inc. 2025&#160;Equity Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Company&#8217;s definitive proxy statement on Schedule&#160;14A filed with the United States Securities and Exchange Commission on April&#160;30,&#160;2025, which description is incorporated herein by reference.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the 2025&#160;Plan is qualified in its entirety by reference to the text of the 2025&#160;Plan, which is filed as Exhibit&#160;10.1 to this Current Report on Form&#160;8-K and is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie1025dff6a3c47129b1c8e38a5bfd26e_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;18,&#160;2025, the Company held its Annual Meeting. Of the 882,580,961&#160;shares of our common stock, par value $0.0001&#160;per share (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) outstanding as of April&#160;21,&#160;2025, 785,427,063&#160;shares of Common Stock were represented, either by attending the Annual Meeting virtually or by proxy, constituting (i)&#160;a quorum under the Company&#8217;s bylaws and (ii)&#160;approximately 89% of the outstanding shares of Common Stock entitled to vote. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below.</span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt">Election of Eight&#160;Directors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one&#160;year term expiring at the 2026&#160;annual meeting of stockholders based on the following results of voting. Each director&#8217;s term continues until the election and qualification of his or her successor, or until his or her earlier retirement, resignation, disqualification, removal, or death.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:35.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.082%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.082%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nominee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;For&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;Withheld&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Broker Non-Votes&#8221;</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick Soon-Shiong, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,233,606</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,502,586</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheryl L. Cohen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,392,571</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,343,621</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Adcock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697,739,427</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,996,765</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael D. Blaszyk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,860,890</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,875,302</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wesley Clark</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699,411,253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324,939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Maxwell, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,967,078</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,769,114</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christobel Selecky</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,825,767</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910,425</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barry J. Simon, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699,183,289</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,552,903</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt">Approval of the ImmunityBio,&#160;Inc. 2025&#160;Equity Incentive Plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The adoption of the ImmunityBio, Inc. 2025&#160;Equity Incentive Plan was approved by our stockholders based on the following results of voting:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.146%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;For&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;Against&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Broker Non-Votes&#8221;</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684,004,688</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,964,761</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,743</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,690,871</span></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt">Ratification of Appointment of Independent Registered Public Accounting Firm.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The appointment of Deloitte&#160;&amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31,&#160;2025 was ratified by our stockholders based on the following results of voting:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.146%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;For&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;Against&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Broker Non-Votes&#8221;</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781,335,243</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236,161</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,659</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie1025dff6a3c47129b1c8e38a5bfd26e_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The document listed below is filed with this Current Report on Form&#160;8-K, as indicated therein (numbered in accordance with Item&#160;601 of Regulation&#160;S&#8209;K).</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:76.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;10.1*#</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ibrx-2025620x8xkexhibit101.htm">ImmunityBio, Inc. 2025&#160;Equity Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover page interactive data file (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">#&#160;&#160;&#160;&#160;Indicates a management contract or compensatory plan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie1025dff6a3c47129b1c8e38a5bfd26e_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">IMMUNITYBIO, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: June&#160;20,&#160;2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ David C. Sachs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">David C. Sachs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ibrx-2025620x8xkexhibit101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i82446ee839ef449e8558eec9bfea8370_36"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">EXHIBIT 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">IMMUNITYBIO, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">2025 EQUITY INCENTIVE PLAN</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:28.13pt;text-decoration:underline">Purposes of the Plan&#59; Award Types</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Purposes of the Plan</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The purposes of this Plan are</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to attract and retain personnel for positions with the Company Group</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to provide additional incentive to Employees, Directors, and Consultants (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), and to promote the success of the Company&#8217;s business.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Award Types</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Plan permits the grant of Incentive Stock Options to any ISO Employee and the grant of Non-statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, and Performance Awards to any Service Provider.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:28.13pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The following definitions are used in this Plan&#58;</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the Board or any Committee that, from time to time, administers the Plan in whole or in part in accordance with Section&#160;4 of the Plan.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the legal and regulatory requirements relating to the administration of equity-based awards and the related issuance of Shares, including requirements under&#58;</font></div><div style="margin-top:12pt;padding-left:144pt;text-indent:-27.89pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18pt">U.S. federal and state corporate laws, </font></div><div style="margin-top:12pt;padding-left:144pt;text-indent:-30.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18pt">U.S. federal and state securities laws,</font></div><div style="margin-top:12pt;padding-left:144pt;text-indent:-33.71pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18pt">U.S. federal and state tax laws, including the Code, </font></div><div style="margin-top:12pt;padding-left:144pt;text-indent:-33.14pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18pt">any stock exchange or quotation system on which the Common Stock is listed or quoted, and</font></div><div style="margin-top:12pt;text-indent:113.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18pt">only to the extent applicable with respect to an Award or Awards, the tax, securities, exchange control, and other laws of any jurisdictions other than the United States where such Award or Awards are, or will be, granted under the Plan.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Reference to a section of an Applicable Law or regulation related to that section includes that section or regulation, any valid regulation or formal regulatory guidance of general or direct applicability promulgated under that section, and any comparable provision of any future legislation, regulation, or formal regulatory guidance of general or direct applicability amending, supplementing or superseding that section or regulation.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, or Performance Awards.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the written or electronic agreement setting forth the terms applicable to an Award granted under the Plan. The Award Agreement is subject to the terms of the Plan.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:25.53pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), acquires ownership of the stock of the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Company that, together with the stock held by such Person, constitutes more than 50%&#160;of the total voting power of the stock of the Company&#59; provided, that for this subsection, the acquisition of additional stock by any one Person, who prior to such acquisition is considered to own more than 50%&#160;of the total voting power of the stock of the Company will not be considered a Change in Control. Further, if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company&#8217;s voting stock immediately prior to the change in ownership, direct or indirect beneficial ownership of 50%&#160;or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event shall not be considered a Change in Control under this Section&#160;2(f)(i). For this purpose, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities&#59; or</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">A change in the effective control of the Company which occurs on the date a majority of members of the Board is replaced during any 12-month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the appointment or election. For purposes of this Section&#160;2(f)(ii), if any Person is considered already to be in effective control of the Company, the acquisition of additional control of the Company by the same Person during the 12-month period will not be considered a Change in Control&#59; or</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">A change in the ownership of a substantial portion of the Company&#8217;s assets which occurs on the date that any Person acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> or </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">) assets from the Company that have a total gross fair market value equal to or more than 50</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">%&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions&#59; provided, that for this </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section&#160;2(f)(iii),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> the following will not constitute a change in the ownership of a substantial portion of the Company&#8217;s assets&#58; </font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">a transfer to an entity that is controlled by the Company&#8217;s stockholders immediately after the transfer, or </font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">a transfer of assets by the Company to&#58; </font></div><div style="margin-top:12pt;text-indent:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:21.44pt">a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company&#8217;s stock,</font></div><div style="margin-top:12pt;text-indent:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.02pt">an entity, 50</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> or more of the total value or voting power of which is owned, directly or indirectly, by the Company, </font></div><div style="margin-top:12pt;text-indent:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.02pt">a Person, that owns, directly or indirectly, 50</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">%&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">or more of the total value or voting power of all the outstanding stock of the Company, or </font></div><div style="margin-top:12pt;text-indent:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:21.44pt">an entity, at least 50</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">%&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">of the total value or voting power of which is owned, directly or indirectly, by a Person described in </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section&#160;2(f)(iii)(2)(A) to Section&#160;2(f)(iii)(2)(C). </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">For this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">definition</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. For this definition, persons will be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. For the avoidance of doubt, wholly-owned subsidiaries of the Company shall not be considered &#8220;Persons&#8221; for purposes of this Section&#160;2(f).</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">A </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">transaction will not be a Change in Control</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">unless the transaction qualifies as a change in control event within the meaning of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Code </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section&#160;409A</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">if</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">a primary purpose is to </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(x)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">change the jurisdiction of the Company&#8217;s incorporation, or (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">y)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the U.S. Internal Revenue Code of 1986, as amended. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a committee of one or more Directors and&#47;or other individuals satisfying Applicable Laws appointed by the Board or a duly authorized committee of the Board in accordance with Section&#160;4 of the Plan.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the common stock of the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means ImmunityBio, Inc., a Delaware corporation, or any of its successors.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the Company, any Parent or Subsidiary of the Company, and any entity that, from time to time and at the time of any determination, directly or indirectly, is in control of, is controlled by or is under common control with the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means any natural person engaged by a member of the Company Group to render bona fide services to such entity, provided the services (i)&#160;are not in connection with the offer or sale of securities in a capital raising transaction, and (ii)&#160;do not directly promote or maintain a market for the Company&#8217;s securities. A Consultant must be a person to whom the issuance of Shares registered on Form S-8 under the Securities Act is permitted. For purposes of clarity, engagement through a third&#160;party to render bona fide services to a member of the Company Group is considered engagement by such member of the Company Group for purposes of this definition.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a member of the Board.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means total and permanent disability as defined in Section&#160;22(e)(3) of the Code, provided that in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Administrator from time to time.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a credit, payable in cash or Shares, made at the discretion of the Administrator or as otherwise provided by the Plan, to the account of a Participant in an amount equal to the dividends or other distributions paid or provided on one Share for each Share represented by an Award of Restricted Stock Units or Performance Award held by such Participant. Dividend Equivalents may be subject to the same vesting restrictions as the related Shares subject to an Award, at the discretion of the Administrator.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means any person, including Officers and Directors, treated by any member of the Company Group as an employee. However, with respect to Incentive Stock Options, an Employee must be employed by the Company or any Parent or Subsidiary of the Company (such an Employee, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">ISO Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;). Neither service as a Director nor payment of a director&#8217;s fee by the Company will be sufficient on its own to constitute &#8220;employment&#8221; by the Company. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the U.S. Securities Exchange Act of 1934.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:25.53pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a program under which (i)&#160;outstanding Awards may be surrendered or cancelled in exchange for awards of the same type (which may have higher or lower Exercise Prices and&#47;or different terms), awards of a different type, and&#47;or cash, (ii)&#160;Participants would have the opportunity to transfer any outstanding Awards to a financial institution or other person or entity selected by the Administrator, and&#47;or (iii)&#160;the Exercise Price of an outstanding Award is increased or reduced. The Administrator will determine the terms and conditions of any Exchange Program in its sole discretion.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.94pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the price payable per Share to exercise an Award.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the last possible day on which an Option or Stock Appreciation Right may be exercised. Any exercise must be completed before midnight U.S. Pacific Time between the Expiration Date and the following date.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of a Share, determined as follows&#58;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">If the Common Stock is listed on any established stock exchange or a national market system, including without limitation the New York Stock Exchange, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market of The Nasdaq Stock Market, the Fair Market Value will be the closing sales price for a Share (or the closing bid, if no sales were reported) as quoted on such exchange or system on the day of determination, as reported in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> or such other source as the Administrator deems reliable&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair Market Value is the mean between the high bid and low asked prices for the Common Stock on the day of determination (or, if no bids and asks were reported on that date on the last Trading Day such bids and asks were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable&#59; or</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">If there is no established market for the Common Stock, the Fair Market Value will be determined in good faith by the Administrator.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if the determination date for the Fair Market Value occurs on a weekend, holiday or other day other than a Trading Day, the Fair Market Value will be the price as determined under subsections&#160;(u)(i) or (u)(ii)&#160;above on the immediately preceding Trading Day, unless otherwise determined by the Administrator. In addition, for purposes of determining the fair market value of a Share for any reason other than the determination of the Exercise Price of Options or Stock Appreciation Rights, fair market value will be determined by the Administrator in a manner compliant with Applicable Laws and applied consistently for such purpose. Note that the determination of fair market value for purposes of Tax Withholding Obligations may be made in the Administrator&#8217;s sole discretion subject to Applicable Laws and is not required to be consistent with the determination of fair market value for other purposes.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a fiscal year of the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:21.44pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the date an Award is granted pursuant to the Plan as described in Section&#160;4(c).</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means an Option that is intended to qualify and by its terms does qualify as an incentive stock option within the meaning of Code Section&#160;422. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means (i)&#160;if permitted by the Administrator, the person designated by the Participant as the Participant&#8217;s beneficiary prior to the Participant&#8217;s death, pursuant to a form acceptable to the Administrator, in its sole discretion, or (ii)&#160;if no such beneficiary has been designated by the Participant prior to the Participant&#8217;s death, the personal representative of the Participant&#8217;s estate or the person(s) to whom the Participant&#8217;s Award is transferred in accordance with the laws of descent and distribution.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Non-statutory Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means an Option that by its terms either does not qualify or is not designated as an Incentive Stock Option.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:19.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a person who is an officer of the Company within the meaning of Section&#160;16 of the Exchange Act.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(bb)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a right to acquire Shares granted under Section&#160;6.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(cc)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:19.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a Director who is not an Employee.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(dd)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a &#8220;parent corporation,&#8221; whether now or hereafter existing, as defined in Code Section&#160;424(e). Unless the context reasonably requires otherwise, references in the Plan or an Award Agreement to &#8220;Parent&#8221; will refer to a Parent of the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ee)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:19.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the holder of an Award.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ff)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.04pt">&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means an Award which may be earned in whole or in part upon attainment of performance goals or other vesting criteria as the Administrator may determine and which may be </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">cash- or stock-denominated and may be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">settled for cash, Shares or other securities or a combination of the foregoing </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> Section&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">10. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(gg)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means Performance Period as defined in Section&#160;10(a)</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(hh)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Period of Restriction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a period during which the transfer of Shares of Restricted Stock is subject to restrictions and therefore that those Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as determined by the Administrator.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means this 2025&#160;Equity Incentive Plan.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(jj)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s 2015&#160;Equity Incentive Plan, as amended from time to time.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(kk)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means Shares issued pursuant to an Award under Section&#160;8 or issued pursuant to the early exercise of an Option or Stock Appreciation Right.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ll)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a bookkeeping entry representing an amount equal to the Fair Market Value, granted under Section&#160;9. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(mm)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:12.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means Code Section&#160;409A.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(nn)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means the U.S. Securities Act of 1933.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(oo)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means an Employee, Director or Consultant. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(pp)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a share of Common Stock as adjusted in accordance with Section 13 of the Plan.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(qq)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means an Award granted under Section 7.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(rr)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.04pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a &#8220;subsidiary corporation,&#8221; whether now or hereafter existing, as defined in Code Section&#160;424(f). Unless the context reasonably requires otherwise, references in the Plan or an Award Agreement to &#8220;Subsidiary&#8221; will refer to a Subsidiary of the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ss)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Withholding Obligations</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means tax, social insurance and social security liability or premium obligations in connection with the Awards, including, without limitation, (i)&#160;all federal, state, and local income, employment, fringe benefit and any other taxes (including the Participant&#8217;s U.S. Federal Insurance Contributions Act (FICA) obligation) that the Company or any Parent or Subsidiary of the Company has either agreed to withhold or has an obligation to withhold, and (ii)&#160;any other taxes or social insurance or social security liabilities or premium the responsibility for which the Participant has, or has agreed to bear, with respect to such Award, the Shares subject to, or other amounts or property payable under, an Award, or otherwise associated with or related to participation in the Plan and with respect to which the Company or any Parent or Subsidiary of the Company has either agreed to withhold or has an obligation to withhold.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(tt)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Ten Percent Owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means an Employee who, at the time an Incentive Stock Option is granted to such Employee, owns stock representing more than 10%&#160;of the voting power of all classes of stock of the Company or any Parent or Subsidiary of the Company, as determined in accordance with Code Section&#160;422. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(uu)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a day that the primary stock exchange, national market system or other trading platform, as applicable, upon which the Common Stock is listed (or otherwise trades regularly, as determined by the Administrator in its sole discretion) is open for trading. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(vv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:18.52pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; means a Change in Control or merger of the Company with or into another entity.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Stock Subject to the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Allocation of Shares to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The maximum aggregate number of Shares that may be subject to Awards and issued or sold under the Plan is&#58; </font></div><div style="margin-top:12pt;text-indent:107.11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt">46,088,027</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Shares, plus </font></div><div style="margin-top:12pt;text-indent:104.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt">any Shares subject to awards granted under the Prior Plan that, on or after the date of stockholder approval of this Plan, expire or otherwise terminate without having been exercised in full, are tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or are forfeited to or repurchased by the Company due to failure to vest, with the maximum number of Shares to be added to this Plan under this clause&#160;(ii) equal to 32,359,674&#160;Shares, plus </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:101.29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt">any additional Shares </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">that </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">become available for issuance under the Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">under </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3(b). </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The Shares may be authorized but unissued Common Stock or Common Stock issued and then reacquired by the Company.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Share Reserve Return</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:107.11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Options and Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If an Option or Stock Appreciation Right expires or becomes unexercisable without having been exercised in full or is surrendered under an Exchange Program, the unissued Shares subject to the Option or Stock Appreciation Right will become available for future issuance under the Plan. </font></div><div style="margin-top:12pt;text-indent:104.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Shares issued upon the exercise of a Stock Appreciation Right (i.e., the net Shares issued) will not become available for future issuance under the Plan&#59; all remaining Shares originally subject to the Stock Appreciation Right will become available for future issuance under the Plan. </font></div><div style="margin-top:12pt;text-indent:101.29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Full-Value Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Shares issued pursuant to Awards of Restricted Stock, Restricted Stock Units, or stock-settled Performance Awards that are reacquired by, or forfeited to, the Company due to failure to vest will become available for future issuance under the Plan. </font></div><div style="margin-top:12pt;text-indent:101.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Withheld Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Shares used to pay the exercise price of an Award or to satisfy Tax Withholding Obligations related to an Award will become available for future issuance under the Plan. </font></div><div style="margin-top:12pt;text-indent:104.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Cash-Settled Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If any portion of an Award under the Plan is paid to a Participant in cash rather than Shares, that cash payment will not reduce the number of Shares available for issuance under the Plan and if such Award was denominated in Shares, the underlying Shares will become available for future issuance under the Plan. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Incentive Stock Options</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The maximum number of Shares that may be issued upon the exercise of Incentive Stock Options will equal 300% of the aggregate Share number stated in Section&#160;3(a) plus, to the extent allowable under Code </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section&#160;422</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, any Shares that become available for issuance under the Plan under </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section&#160;3(b).</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Adjustment</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The numbers provided in Sections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3(a) and 3(c) will be adjusted as a result of changes in capitalization and any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">other</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> adjustments under Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">13. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Substitute Awards</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If the Administrator grants Awards in substitution for equity compensation awards outstanding under a plan maintained by an entity acquired by or that becomes a part of any member of the Company Group, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">grant</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> of those substitute Awards will not decrease the number of Shares available for issuance under the Plan.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:25.53pt;text-decoration:underline">Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as is sufficient to satisfy the requirements of the Plan. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Administration of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">Different Committees may administer the Plan with respect to different groups of Service Providers.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">To the extent permitted by Applicable Laws, the Board or a Committee of the Board may delegate to one or more individuals the authority to exercise some or all powers of the Administrator. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Powers of the Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Subject to the provisions of the Plan, and, in the case of a Committee or delegated individuals under Section&#160;4(a)(ii) of the Plan, subject to the specific duties delegated or limitations specified, the Administrator will have the authority, in its sole discretion, to&#58;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">determine Fair Market Value&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">approve forms of Award Agreements for use under the Plan&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">determine the Awards to be granted hereunder from time to time and select the Service Providers to whom such Awards are granted&#59;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">determine the number of Shares to be covered by each Award granted hereunder&#59;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">determine the terms and conditions, not inconsistent with the terms of the Plan, of each Award granted hereunder, including but not limited to the exercise price, the time or times when the Award may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding the Award or the Shares relating thereto, based in each case on such factors as the Administrator may determine&#59;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">temporarily suspend the exercisability of any Award if the Administrator deems such suspension to be necessary or appropriate for administrative purposes (including, if applicable, a determination of whether a termination of a Participant&#8217;s status as a Service Provider is for &#8220;cause&#8221; (as defined in the applicable Award Agreement) that results in the forfeiture of the vested portion of an Award held by such Participant, to the extent provided in the applicable Award Agreement) or to comply with Applicable Laws, provided that, to the extent permitted by Applicable Laws, such suspension must be lifted prior to the expiration of the maximum term and post-termination exercisability period of an Award&#59;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:17.95pt">institute and determine the terms and conditions of an Exchange Program, including, subject to Section&#160;19(c), implementing an Exchange Program unilaterally without the consent of the applicable Award holder(s) or the stockholders of the Company&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:15.04pt">construe and interpret the terms of the Plan and all Awards granted pursuant to the Plan&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">establish, amend and rescind rules and regulations and adopt sub-plans relating to the Plan, including rules, regulations and sub-plans for the purposes of facilitating compliance with applicable non-U.S. laws, easing the administration of the Plan and&#47;or obtaining tax-favorable treatment for Awards granted to Service Providers located outside the U.S., in each case as the Administrator may deem necessary or advisable&#59;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">modify or amend each Award (subject to Section&#160;19), including the authority to extend the post-termination exercisability period of any Awards and to extend the maximum term of an Option (subject to Section&#160;6(d)&#59; </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">allow Participants to satisfy Tax Withholding Obligations in any manner permitted by Section 16&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:17.95pt">determine whether Awards will be settled in Shares, cash or in any combination thereof&#59;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:15.04pt">make all other determinations deemed necessary or advisable for administering the Plan, including authorizing any person to take any steps and execute, on behalf of the Company, any documents required for an Award previously granted by the Administrator to be effective&#59; and</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:15.61pt">allow Participants to defer the receipt of the payment of cash or the delivery of Shares otherwise due to </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">such </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> under an Award. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Grant Date of an Award will be the date that the Administrator makes the determination granting such Award or may be a later date if such later date is designated by the Administrator on the date of the determination or under an automatic grant policy. Notice of the determination will be provided to each Participant within a reasonable time after the Grant Date. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator may waive any terms, conditions or restrictions.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Except as otherwise provided by the Administrator, any fractional Shares that result from the adjustment of Awards will be canceled. Any fractional Shares that result from vesting percentages will be accumulated and vested on the date that an accumulated full Share is vested. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:25.53pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Company may deliver by e-mail or other electronic means (including posting on a website maintained by the Company or by a third party under contract with the Company or another member of the Company Group) all documents relating to the Plan or any Award and all other documents that the Company is required to deliver to its security holders (including prospectuses, annual reports and proxy statements). </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Choice of Law&#59; Choice of Forum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Plan, all Awards and all determinations made and actions taken under the Plan, to the extent not otherwise governed by the laws of the United States, will be governed by the laws of the State of Delaware without giving effect to principles of conflicts of law. For purposes of litigating any dispute that arises under this Plan, a Participant&#8217;s acceptance of an Award is his or her consent to the jurisdiction of the State of Delaware, and agreement that any such litigation will be conducted in Delaware Court of Chancery, or the federal courts for the United States for the District of Delaware, and no other courts, regardless of where a Participant&#8217;s services are performed. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Effect of Administrator&#8217;s Decision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator&#8217;s decisions, determinations and interpretations will be final and binding on all Participants and other persons and will be given the maximum deference permitted by Applicable Laws. A prior decision, determination or interpretation with respect to the Plan or an Award made by a person who had not been delegated proper authority to make such decision, determination or interpretation will have effect as of the time it was originally made if and to the extent that the Board or a Committee of the Board formally adopts such prior decision, determination or interpretation.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Non-statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and Performance Awards may be granted to all types of Service Providers. Incentive Stock Options may be granted only to ISO Employees. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Stock Option Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Each Option will be evidenced by an Award Agreement that specifies the number of Shares subject to the Option, its Exercise Price, its Expiration Date, and such other terms and conditions as the Administrator determines. Each Option will be designated as either an Incentive Stock Option or a Non-statutory Stock Option. An Option not designated as an Incentive Stock Option is a Non-statutory Stock Option. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Exercise Price for the Shares to be issued upon exercise of an Option will be determined by the Administrator and stated in the Award Agreement, subject to the following&#58;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">In the case of an Incentive Stock Option&#58;</font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">granted to a Ten&#160;Percent Owner, the Exercise Price for the Shares to be issued will be no less than 110% of the Fair Market Value on the date of grant&#59; and</font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">granted to any ISO Employee other than a Ten&#160;Percent Owner, the Exercise Price for the Shares to be issued will be no less than 100% of the Fair Market Value on the date of grant.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">In the case of a Non-statutory Stock Option, the Exercise Price for the Shares to be issued will be no less than 100% of the Fair Market Value on the date of grant.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">Notwithstanding the foregoing, Options may be granted with an Exercise Price of less than 100% of the Fair Market Value on the date of grant (i)&#160;pursuant to a transaction described in, and in a manner consistent with, Code Section&#160;424(a) or (ii)&#160;if the applicable Service Provider receiving the Option is located in a non-U.S. country or jurisdiction and, to the knowledge of the Company, is not subject to the income tax laws of the United States. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Form of Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator will determine the acceptable form(s) of consideration for exercising an Option. Unless the Administrator determines otherwise, the consideration may consist of any one or more or combination of the following, to the extent permitted by Applicable Laws&#58; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">Cash (including a wire transfer or other cash equivalents)&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">check (or its equivalent)&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">promissory note, if and to the extent approved by the Administrator&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">other Shares that have a fair market value on the date of surrender equal to the aggregate Exercise Price of the Shares as to which such Option will be exercised. To the extent not prohibited by the Administrator, this will include the ability to tender Shares to exercise the Option and then use the Shares received on exercise to exercise the Option with respect to additional Shares&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">consideration received by the Company under a cashless exercise arrangement (whether through a broker or otherwise) implemented by the Company for the exercise of Options that has been approved by the Administrator, if and to the extent permitted by the Company with respect to a particular Award&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">consideration received by the Company under a net exercise arrangement under which Shares are withheld from otherwise deliverable Shares that has been approved by the Administrator, if and to the extent permitted by the Company with respect to a particular Award&#59; and </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:17.95pt">any other consideration or method of payment to issue Shares (provided that other forms of considerations may only be approved by the Administrator).</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The Administrator has the power to remove or limit any of the above forms of consideration for exercising an Option, except for the payment of cash, at any time, including after the grant of an Option, in its sole discretion. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Term of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The term of each Option will be determined by the Administrator and stated in the Award Agreement, provided that, in the case of an Incentive Stock Option&#58; (a)&#160;granted to a Ten&#160;Percent Owner, the Option may not be exercisable after the expiration of five&#160;years from the date such Option is granted, or such shorter term as may be provided in the Award Agreement&#59; and (b)&#160;granted to an ISO Employee other than a Ten&#160;Percent Owner, the Option may not be exercisable after the expiration of ten&#160;years from the date such Option is granted term, or such shorter term as may be provided in the Award Agreement. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Incentive Stock Option Limitations.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">To the extent that the aggregate fair market value of the shares with respect to which incentive stock options under Code Section&#160;422(b) are exercisable for the first&#160;time by a Participant during any calendar year (under all plans and agreements of the Company Group) exceeds $100,000, the incentive stock options whose value exceeds $100,000 will be treated as non-statutory stock options. Incentive stock options will be considered in the order in which they were granted. For this purpose, the fair market value of the shares subject to an option will be determined as of the grant date of each option.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">If an Option is designated in the Administrator action that granted it as an Incentive Stock Option but the terms of the Option do not comply with Sections&#160;6(b) and 6(d), then the Option will not qualify as an Incentive Stock Option. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:25.53pt;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. An Option is exercised when the Company receives&#58; (x)&#160;a notice of exercise (in such form and in accordance with the procedures as the Administrator may specify from time to time) from the person entitled to exercise the Option and (y)&#160;full payment for the Shares with respect to which the Option is exercised (together with applicable Tax Withholding Obligations). Shares issued upon exercise of an Option will be issued in the name of the Participant. Until the Shares are issued (as evidenced by the entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to an Option, despite the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. Unless otherwise provided by the Administrator, an Option may not be exercised for a fraction of a Share. Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan (except as provided in Section&#160;3(b)) and for purchase under the Option, by the number of Shares as to which the Option is exercised. </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt;text-decoration:underline">Termination of Relationship as a Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If a Participant ceases to be a Service Provider, other than upon such cessation as the result of the Participant&#8217;s death or Disability, the Participant may exercise his or her Option within 30&#160;days of such cessation, or such longer period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement or Section&#160;6(d), as applicable) to the extent that the Option is vested on the date of cessation&#59; provided that, if so determined by the Administrator and specified in the applicable Award Agreement, if a Participant ceases to be a Service Provider as a result of the termination of the Participant&#8217;s status as a Service Provider for &#8220;cause&#8221; (as defined in the applicable Award Agreement), the period of time in which the Participant may exercise the Participant&#8217;s Option may be less than 30&#160;days following such cessation or the Option (including any portion of the Option that has vested) may immediately terminate upon such cessation. Unless otherwise provided by the Administrator, if on the date of cessation the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Plan on the date of cessation. If after cessation the Participant does not exercise his or her Option within the time specified herein, the Option will terminate, and the Shares covered by that Option will revert to the Plan. </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt;text-decoration:underline">Disability of Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If a Participant ceases to be a Service Provider as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option within 6&#160;months of cessation, or such longer period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement or Section&#160;6(d), as applicable) to the extent the Option is vested on the date of cessation. Unless otherwise provided by the Administrator, if on the date of cessation due to Disability the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan on the date of cessation. If after cessation the Participant does not exercise his or her Option within the time specified herein, the Option will terminate, and the Shares covered by that Option will revert to the Plan. </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt;text-decoration:underline">Death of Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If a Participant dies while a Service Provider, the Option may be exercised within 6&#160;months following the Participant&#8217;s death, or within such longer period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement or Section&#160;6(d), as applicable) to the extent that the Option is vested on the date of death, by the deceased Participant&#8217;s Legal Beneficiary. Unless otherwise provided by the Administrator or set forth in the Award Agreement or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable, if on the date of cessation due to death the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan on the date of cessation. If after cessation the Participant&#8217;s Legal Beneficiary does not exercise the Option within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan. If the Option is exercised pursuant to this Section&#160;6(f)(iii), the deceased Participant&#8217;s Legal Beneficiary will be subject to the terms of this Plan and the Award Agreement, including but not limited to the restrictions on transferability and forfeitability applicable to the deceased Participant. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Expiration of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Subject to Section&#160;6(d), an Option&#8217;s Expiration Date will be set forth in the Award Agreement. An Option may expire before its expiration date under the Plan (including pursuant to Sections&#160;6(f), 13, 14, or 17(d)) or under the Award Agreement. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Tolling of Expiration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If exercising an Option prior to its expiration is not permitted because of Applicable Laws, other than the rules of any stock exchange or quotation system on which the Common Stock is listed or quoted, the Option will remain exercisable until 30&#160;days after the first date on which exercise no longer would be prevented by such provisions&#59; provided that this tolling of expiration shall not apply if and to the extent the holder of such Option is a United States taxpayer and the tolling would result in a violation of Section&#160;409A such that the Option would be subject to additional taxation under Section&#160;409A. If this would result in the Option remaining exercisable past its Expiration Date, then unless earlier terminated pursuant to Section&#160;14, the Option will remain exercisable only until the end of the later of (i)&#160;the first&#160;day on which its exercise would not be prevented by Section&#160;20(a) and (ii)&#160;its Expiration Date. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:28.13pt;text-decoration:underline">Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Stock Appreciation Right Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify the number of Shares subject to the Stock Appreciation Right, its per share Exercise Price, its Expiration Date, and such other terms and conditions as the Administrator determines. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Exercise Price of a Stock Appreciation Right will be determined by the Administrator, subject to the following&#58; </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">The Exercise Price will be no less than 100% of the Fair Market Value on the date of grant.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">Notwithstanding the foregoing, Stock Appreciation Rights may be granted with an Exercise Price of less than 100% of the Fair Market Value on the date of grant (1)&#160;pursuant to a transaction described in, and in a manner consistent with, Code Section&#160;424(a) or (2)&#160;if the applicable Service Provider receiving the Stock Appreciation Right is located in a non-U.S. country or jurisdiction and, to the knowledge of the Company, is not subject to the income tax laws of the United States.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Payment of Stock Appreciation Right Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Payment upon Stock Appreciation Right exercise may be made in cash, in Shares (which, on the date of exercise, have an aggregate fair market value equal to the amount of payment to be made under the Award), or any combination of cash and Shares, with the determination of form of payment made by the Administrator. When a Participant exercises a Stock Appreciation Right, he or she will be entitled to receive a payment from the Company equal to&#58;</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">the excess, if any, of the fair market value per Share on the date of exercise over the Exercise Price multiplied by </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">the number of Shares with respect to which the Stock Appreciation Right is exercised.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Term of Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The term of each Stock Appreciation Right will be determined by the Administrator and stated in the Award Agreement.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Exercise of Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. A Stock Appreciation Right is exercised when the Company receives a notice of exercise (in such form as the Administrator may specify from time to time) from a person entitled to exercise the Stock Appreciation Right. Shares issued upon exercise of a Stock Appreciation Right will be issued in the name of the Participant. Until the Shares are issued (as evidenced by the entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to a Stock Appreciation Right, despite the exercise of the Stock Appreciation Right. The Company will issue (or cause to be issued) such Shares promptly after the Stock Appreciation Right is exercised. Unless provided otherwise by the Administrator, a Stock Appreciation Right may not be exercised for a fraction of a Share. Exercising a Stock Appreciation Right in any manner will decrease the number of Shares thereafter available under the Stock Appreciation Right by the number of Shares as to which the Stock Appreciation Right is exercised.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:25.53pt;text-decoration:underline">Expiration of Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. A Stock Appreciation Right&#8217;s Expiration Date will be set forth in the Award Agreement. A Stock Appreciation Right may expire before its expiration date under the Plan (including pursuant to Sections&#160;13, 14, or 17(c)) or under the Award Agreement. Notwithstanding the foregoing, the rules of Section&#160;6(f) relating to exercise also will apply to Stock Appreciation Rights.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Tolling of Expiration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If exercising a Stock Appreciation Right prior to its expiration is not permitted because of Applicable Laws, other than the rules of any stock exchange or quotation system on which the Common Stock is listed or quoted, the Stock Appreciation Right will remain exercisable until 30&#160;days after the first date on which exercise no longer would be prevented by such provisions&#59; provided that this tolling of expiration shall not apply if and to the extent the holder of such Stock Appreciation Right is a United States taxpayer and the tolling would result in a violation of Section&#160;409A such that the Stock Appreciation Right would be subject to additional taxation under Section&#160;409A. If this would result in the Stock Appreciation Right remaining exercisable past its Expiration Date, then unless earlier terminated pursuant to Section&#160;14, the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Stock Appreciation Right will remain exercisable only until the end of the later of (i)&#160;the first day on which its exercise would not be prevented by Section&#160;20(a) and (ii)&#160;its Expiration Date.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:28.13pt;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Restricted Stock Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the number of Shares subject to the Award of Restricted Stock and such other terms and conditions as the Administrator determines. For the avoidance of doubt, Restricted Stock may be granted without any Period of Restriction (e.g.,&#160;fully vested stock bonuses). Unless the Administrator determines otherwise, Shares of Restricted Stock will be held in escrow while subject to any Period of Restriction.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">Except as provided in this Section&#160;8(b) or the Award Agreement, while unvested, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">While unvested, Service Providers holding Shares of Restricted Stock may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">Service Providers holding Shares covered by an Award of Restricted Stock will not be entitled to receive dividends and other distributions paid with respect to such Shares while such Shares are unvested, unless the Administrator provides otherwise. If the Administrator provides that dividends and distributions will be received and any such dividends or distributions are paid in cash they will be subject to the same provisions regarding forfeitability as the Shares with respect to which they were paid and if such dividend or distributions are paid in Shares, the Shares will be subject to the same restrictions on transferability and forfeitability as the Shares with respect to which they were paid and, unless the Administrator determines otherwise, the Company will hold such dividends until the restrictions on the Shares with respect to which they were paid have lapsed.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">Except as otherwise provided in this Section&#160;8(b) or an Award Agreement, Shares covered by an Award of Restricted Stock will be released from escrow, if applicable, when practicable after the end of the applicable Period of Restriction.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">The Administrator may impose (prior to grant) or remove (at any time) any restrictions on Shares covered by an Award of Restricted Stock. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:28.13pt;text-decoration:underline">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Restricted Stock Unit Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Each Award of Restricted Stock Units will be evidenced by an Award Agreement that will specify the number of Restricted Stock Units subject to the Award of Restricted Stock Units and such other terms and conditions as the Administrator determines.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Vesting Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator will set vesting criteria, if any, that, depending on the extent to which the criteria are met, will determine the number of Restricted Stock Units paid out to the Participant. The Administrator may set vesting criteria on any basis determined by the Administrator.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Vested Restricted Stock Units.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> Upon meeting any applicable vesting criteria, the Participant will have vested in the Restricted Stock Units and the Restricted Stock Units will be settled as </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">determined in Section&#160;9(d). The Administrator may reduce or waive any criteria that must be met to vest in the Restricted Stock Units. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Form and Timing of Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Settlement of vested Restricted Stock Units will be made at the time(s) set forth in the Award Agreement. Vested Restricted Stock Units will be settled in cash, Shares, or a combination of both, pursuant to the terms set forth in the Award Agreement. Service Providers holding Restricted Stock Units will not be entitled to receive Dividend Equivalents with respect to such Restricted Stock Units, unless the Administrator provides otherwise.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Performance Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Award Agreemen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">t. Each Performance Award will be evidenced by an Award Agreement that will specify the specify any time period during which any performance objectives or other vesting provisions, if any, will be measured (&#8220;Performance Period&#8221;), and such other terms and conditions as the Administrator determines.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Objectives or Vesting Provisions and Other Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator will set objectives or vesting provisions that, depending on the extent to which the objectives or vesting provisions are met, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">will determine the value of the payout for the Performance Awards. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The Administrator may set vesting criteria based upon the achievement of Company-wide, divisional, business unit, or individual goals (that may include continued employment or service) or any other basis determined by the Administrator in its sole discretion.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Form and Timing of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Payment of earned Performance Awards will be made at the time(s) specified in the Award Agreement. Payment with respect to earned Performance Awards will be made in cash, in Shares of equivalent value, or any combination of cash and Shares, with the determination of form of payment made by the Administrator at the time of payment or, in the discretion of the Administrator, at the time of grant. Service Providers holding Performance Awards will not be entitled to receive Dividend Equivalents with respect to such Performance Awards, unless the Administrator provides otherwise.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Value of Performance Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Each Performance Award&#8217;s threshold, target, and maximum payout values will be established by the Administrator on or before the Grant Date. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Earning Performance Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. After an applicable Performance Period has ended, the holder of a Performance Award will be entitled to receive a payout for the Performance Award earned by the Participant over the Performance Period. The Administrator may reduce or waive any performance objectives or other vesting provisions for such Performance Award. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Leaves of Absence&#47;Reduced or Part-time Work Schedule&#47;Transfer Between Locations&#47;Change of Statu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">s. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Leaves of Absence&#47;Reduced or Part-time Work Schedule&#47;Transfer Between Locations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Unless the Administrator provides otherwise or as otherwise required by Applicable Laws, vesting of Awards granted hereunder will be adjusted or suspended during any unpaid leave of absence in accordance with the Company&#8217;s leave of absence policy in effect at the time of such leave. A Participant will not cease to be an Employee in the case of (i)&#160;any leave of absence approved by the Company or (ii)&#160;transfers between locations of the Company or within the Company Group. In addition, unless the Administrator provides otherwise or as otherwise required by Applicable Laws, if, after the date of grant of a Participant&#8217;s Award, the Participant commences working on a part-time or reduced work schedule basis, the vesting of such Award will be adjusted in accordance with the Company&#8217;s reduced work schedule&#47; part-time policy then in effect. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Adjustments or suspensions of vesting pursuant to this Section shall be accomplished in a manner that is exempt from or complies with the requirements of Code Section&#160;409A and the regulations and guidance thereunder. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Employment Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. A Participant will not cease to be a Service Provider in the case of (i)&#160;any leave of absence approved by the Company or (ii)&#160;transfers between locations of the Company (or member of the Company Group) or between the Company or any member of the Company Group. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Incentive Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. With respect to Incentive Stock Options, no such leave may exceed 3&#160;months, unless reemployment upon expiration of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, then 6&#160;months following the first&#160;day of such leave any Incentive Stock Option held by a Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Non-statutory Stock Option. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Transferability of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Unless determined otherwise by the Administrator, or otherwise required by Applicable Laws, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant. If the Administrator makes an Award transferable, the Award will be limited by any additional terms and conditions imposed by the Administrator. Any unauthorized transfer of an Award will be void. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Adjustments&#59; Dissolution or Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If any extraordinary dividend or distribution (whether in cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, reclassification, repurchase, or exchange of Shares or other securities of the Company, other change in the corporate structure of the Company affecting the Shares, or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Topic&#160;718 (or any of its successors) affecting the Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> occurs</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> (including a Change in Control),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> the Administrator, to prevent diminution or enlargement of the benefits or potential benefits intended to be </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> under the Plan, will adjust the number and class of shares that may be delivered under the Plan and&#47;or the number, class, and&#47;or price of shares covered by each outstanding Award, and the numerical Share limits in Section&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3. Notwithstanding the foregoing, the conversion of any convertible securities of the Company and ordinary course repurchases of Shares or other securities of the Company will not be treated as an event that will require adjustment. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Dissolution or Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant of such proposed action in writing or electronically, at such time prior to the effective date of such proposed action as the Administrator determines. To the extent it has not been previously exercised (with respect to an Option or Stock Appreciation Right), vested (with respect to Restricted Stock) or settled (with respect to any other Awards), an Award will terminate immediately prior to the consummation of that proposed action.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Change in Control or Merge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">r. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Administrator Discretion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If a Transaction occurs, each outstanding Award will be treated as the Administrator determines (subject to the provisions of this Section&#160;14), without a Participant&#8217;s consent, including that such Award be continued by the successor corporation or a Parent or Subsidiary of the successor corporation (or an affiliate thereof) or that the vesting of any such Awards may accelerate automatically upon consummation of a Transaction. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Identical Treatment Not Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator need not take the same action or actions with respect to all Awards or portions thereof or with respect to all Participants. The Administrator may take different actions with respect to the vested and unvested portions of an Award. The Administrator will not be required to treat all Awards similarly in the Transaction. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Continuation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. An Award will be considered continued if, following the Transaction&#58; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">the Award confers the right to purchase or receive, for each Share subject to the Award immediately prior to the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, the consideration (whether stock, cash, or other securities or property) received in the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> by holders of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> for each Share held on the effective date of the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> (and if holders were offered a choice of consideration, the type of consideration </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">received</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> by the holders of a majority of the outstanding Shares</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and the Award otherwise is continued in accordance with its terms (including vesting criteria), subject to Section&#160;14(c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii) below and Section&#160;13(a)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> provided that if </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> consideration received in the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">exercising</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> an Option or Stock Appreciation Right or upon the payout of a Restricted Stock Unit, or Performance </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, for each Share subject to such Award, to be solely common stock of the successor corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Stock in the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Transaction&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">provided further, for the avoidance of doubt, the Administrator may determine that, for purposes of this Section&#160;14(c) of the Plan, the Company is the successor corporation with respect to some or all Awards&#59; or</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">the Award is terminated in exchange for an amount of cash and&#47;or property, if any, equal to the amount that would have been attained upon the exercise of such Award or realization of the Participant&#8217;s rights as of the date of the occurrence of the Transaction. Any such cash or property may be subjected to any escrow applicable to holders of Common Stock in the Transaction. If as of the date of the occurrence of the Transaction the Administrator determines that no amount would have been attained upon the exercise of such Award or realization of the Participant&#8217;s rights, then such Award may be terminated by the Company without payment. The amount of cash or property can be subjected to vesting and paid to the Participant over the vesting schedule of the Award as in effect immediately prior to the Transaction.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">Notwithstanding anything in this Section&#160;14(c) to the contrary, an Award that vests, is earned or paid-out upon the satisfaction of one or more performance goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant&#8217;s consent, in all cases, unless specifically provided otherwise under the applicable Award Agreement or other written agreement authorized by the Administrator between the Participant and the Company or any Parent or Subsidiary of the Company, as applicable&#59; provided, however, a modification to such performance goals only to reflect the successor corporation&#8217;s post-Transaction corporate structure will not invalidate an otherwise valid Award assumption.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator will have authority to modify Awards in connection with a Transaction, without a Participant&#8217;s consent&#58; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">in a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">manner</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> that causes the Awards to lose their tax-preferred status or re-start any holding or other period required to achieve beneficial tax treatment&#59; </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">to terminate any right a Participant has to exercise an Option or Stock Appreciation Right prior to vesting in the Shares subject to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Award</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> (i.e.,&#160;&#8220;early exercise&#8221;), so that following the closing of the Transaction the Option or Stock Appreciation Right may only be exercised only to the extent it is vested&#59; </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.29pt">to reduce the Exercise Price subject to the Award in a manner that is disproportionate to the increase in the number of Shares subject to the Award, as long as the amount that would be received upon </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">exercise</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> of the Award immediately before and immediately following the closing of the Transaction is equivalent and the adjustment complies with U.S. Treasury Regulation Section&#160;1.409A-1(b)(v)(D)&#59; and </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:20.86pt">to suspend a Participant&#8217;s right to exercise an Option during a limited period of time preceding and or following the closing of the Transaction without Participant consent if such suspension is administratively necessary or advisable to permit or facilitate the closing of the Transaction. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Non-Continuation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If the successor corporation does not continue an Award (or some portion such Award), the Participant will fully vest in (and have the right to exercise) 100% of the then-unvested Shares subject to his or her outstanding Options and Stock Appreciation Rights, all restrictions on 100% of the Participant&#8217;s outstanding Restricted Stock and Restricted Stock Units will lapse, and, regarding 100% of Participant&#8217;s outstanding Awards with performance-based vesting, all performance goals or other vesting criteria will be treated as achieved at 100% of target levels and all other terms and conditions met, in all cases, unless specifically provided otherwise under the applicable Award Agreement or other written agreement authorized by the Administrator between the Participant and the Company or any Parent or Subsidiary of the Company, as applicable. In no event will vesting of an Award accelerate as to more than 100% of the Award. Unless specifically provided otherwise under the applicable Award Agreement or other written agreement authorized by the Administrator between the Participant and the Company or any Parent or Subsidiary of the Company, as applicable, if Options or Stock Appreciation Rights are not continued when a Transaction occurs, the Administrator will notify the Participant at such time prior to the effective date of such Transaction as the Administrator determines in writing or electronically that the Participant&#8217;s vested Options or Stock Appreciation Rights (after considering the applicable vesting acceleration, if any) will be exercisable for a period of time determined by the Administrator in its sole discretion and all of the Participant&#8217;s Options or Stock Appreciation Rights will terminate upon the expiration of such period (whether vested or unvested).</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Outside Director Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt">With respect to Awards granted to an Outside Director, in the event of a Change in Control, the Participant will fully vest in and have the right to exercise outstanding Options and&#47;or Stock Appreciation Rights as to all of the Shares underlying such Award, including those Shares which otherwise would not be vested or exercisable, all restrictions on other outstanding Awards will lapse, and, with respect to Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at 100% of target levels and all other terms and conditions met, unless specifically provided otherwise under the applicable Award Agreement, a Company policy related to Director compensation, or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable, that specifically references this default rule.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">No Outside Director may be paid, issued or granted, in any Fiscal Year, cash retainer fees and equity awards (including any Awards issued under this Plan) with an aggregate value greater than $750,000 (increased to $1,000,000 in connection with the Outside Director&#8217;s initial year of service), with the value of each equity award based on its grant date fair value (determined in accordance with U.S. generally accepted accounting principles) for purposes of this limit. Any cash compensation paid, or Awards granted to an individual for his or her services as an Employee or as a Consultant (other than as an Outside Director), will not count for purposes of the limitation under this Section&#160;15(b).</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Withholding Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Prior to the delivery of any Shares or cash under an Award (or exercise thereof) or such earlier time as any Tax Withholding Obligations are due, the Company may deduct </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy any Tax Withholding Obligations with respect to such Award or Shares subject to an Award (including upon grant, vesting, exercise or settlement of an Award, as applicable).</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Withholding Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator, in its sole discretion and under such procedures as it may specify from time to time, may elect to satisfy such Tax Withholding Obligations, in whole or in part (including in combination) by (without limitation) (i)&#160;requiring the Participant to pay cash, check or other cash equivalents, (ii)&#160;withholding otherwise deliverable cash (including cash from the sale of Shares issued to the Participant) or Shares having a fair market value equal to the amount required to be withheld or such greater amount (including up to a maximum statutory amount) as the Administrator may determine or permit if such amount does not result in unfavorable financial accounting treatment, as the Administrator determines, (iii)&#160;requiring the sale of Shares issued pursuant to an Award (or exercise thereof) having a fair market value equal to the minimum statutory amount applicable in a Participant&#8217;s jurisdiction or any greater amount as the Administrator may determine or permit if such greater amount would not result in unfavorable financial accounting treatment, as the Administrator determines, (iv)&#160;requiring the Participant to deliver to the Company already-owned Shares having a fair market value equal to the minimum statutory amount required to be withheld or any greater amount as the Administrator may determine or permit if such greater amount would not result in unfavorable financial accounting treatment, as the Administrator determines, (v)&#160;requiring the Participant to engage in a cashless exercise transaction (whether through a broker or otherwise) implemented by the Company in connection with the Plan, (vi)&#160;having the Company or any Parent or Subsidiary of the Company withhold from wages or any other cash amount due or to become due to the Participant and payable by the Company or any Parent or Subsidiary of the Company, or (vii)&#160;such other consideration and method of payment for the meeting of Tax Withholding Obligations as the Administrator may determine to the extent permitted by Applicable Laws, provided that, in all instances, the satisfaction of the Tax Withholding Obligations will not result in any adverse accounting consequence to the Company, as the Administrator may determine. The fair market value of the Shares to be withheld or delivered will be determined as of the date the tax is required to be withheld or such other date as Administrator determines is applicable or appropriate with respect to the Tax Withholding Obligations calculation.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Compliance With Code Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Unless the Administrator determines that compliance with Section&#160;409A is desired, it is intended that Awards will be designed and operated so that they are either exempt or excepted from the application of Section&#160;409A or comply with any requirements necessary to avoid the imposition of additional tax under Code Section&#160;409A(a)(1)(B) so that the grant, payment, settlement and deferral will not be subject to the additional tax or interest applicable under Section&#160;409A and the Plan and each Award Agreement will be interpreted consistent with this intent. This Section&#160;16(c) of the Plan is not a guarantee to any Participant of the consequences of his or her Awards. Except as otherwise provided by the Administrator, each payment or benefit under this Plan and under each Award Agreement is intended to constitute a separate payment for purposes of U.S.&#160;Treasury Regulation Section&#160;1.409A-2(b)(2).</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Responsibility for Tax Consequences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. In no event will the Company or any Parent or Subsidiary of the Company have any responsibility, liability or obligation to reimburse, indemnify or hold harmless any Participant for any taxes that may be imposed or other costs that may be incurred with respect to an Award as a result of Section 409A or any other Applicable Laws. The Company (i)&#160;makes no representations or undertakings regarding the treatment of any Tax Withholding Obligations in connection with any aspect of an Award, including, but not limited to, the grant, vesting, exercise or settlement of an Award, as applicable, the subsequent sale of Shares acquired in connection with an Award and the issuance of any dividends or other distributions in connection with an Award, and (ii)&#160;does not commit to and is under no obligation to structure the terms of an Award to reduce or eliminate a Participant&#8217;s liability for Tax Withholding Obligations or achieve any particular tax result. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Other Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">No Effect on Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Neither the Plan nor any Award will confer upon a Participant any right with respect to continuing the Participant&#8217;s relationship as a Service Provider with the Company or any member of the Company Group, as applicable, nor will they interfere with the Participant&#8217;s right, or the right of the Company or any member of the Company Group, to terminate that relationship at any time, with or without cause, to the extent permitted by Applicable Laws.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Interpretation and Rules of Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; when used herein shall be deemed in each case to be followed by the words &#8220;without limitation.&#8221; </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Plan Governs</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of any Grant Agreement, the terms and conditions of the Plan will prevail</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Forfeiture Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">All Awards granted under the Plan will be subject to recoupment under any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Laws. In addition, the Administrator may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Administrator determines necessary or appropriate, including without limitation to any reacquisition right regarding previously acquired Shares or other cash or property. Unless this Section&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">17(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> is specifically mentioned and waived in an Award Agreement or other document, no recovery of compensation under a clawback policy or otherwise will be an event that triggers or contributes to any right of a Participant to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company or </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">a member of the Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">The Administrator may specify in an Award Agreement that the Participant&#8217;s rights, payments, and benefits with respect to an Award will be subject to reduction, cancellation, forfeiture, or recoupment upon the occurrence of specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, but will not be limited to, termination of such Participant&#8217;s status as Service Provider for cause or any specified action or inaction by a Participant that would constitute cause for termination of such Participant&#8217;s status as a Service Provider. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator, in its discretion, may provide in the Award Agreement evidencing any Award that the Participant will be entitled to receive Dividend Equivalents with respect to the payment of cash dividends on Shares having a record date prior to the date on which the Awards are settled or forfeited. Dividend Equivalents, if any, will be credited to an Award in such manner and subject to such terms and conditions as determined by the Administrator in its sole discretion. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Term of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Subject to Section&#160;21, the Plan will become effective upon the later to occur of (x)&#160;its adoption by the Board or (y)&#160;its approval by the Company&#8217;s stockholders. The Plan will continue in effect for a term of ten&#160;(10) years from the first to occur of the Board or stockholder approval of the Plan, unless terminated earlier under Section&#160;19 of the Plan. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Amendment and Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Administrator, in its sole discretion, may amend, alter, suspend or terminate the Plan or any part thereof, at any time and for any reason. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Stockholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Company will obtain stockholder approval of any Plan amendment to the extent necessary or desirable to comply with Applicable Laws. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt">Consent of Participants Generally Required. Subject to Section&#160;19(d) below, no amendment, alteration, suspension or termination of the Plan or an Award under it will materially impair the rights of any Participant without a signed, written agreement authorized by the Administrator between the Participant and the Company. Termination of the Plan will not affect the Administrator&#8217;s ability to exercise the powers granted to it regarding Awards granted under the Plan prior to such termination. </font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">Exceptions to Consent Requirement. </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:26.11pt">A Participant&#8217;s rights will not be deemed to have been materially impaired by any amendment, alteration, suspension or termination if the Administrator determines in its sole discretion that such action taken as a whole, does not materially impair the Participant&#8217;s rights&#59; and </font></div><div style="margin-top:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.2pt">Subject to any limitations of Applicable Laws, the Administrator may amend the terms of any one or more Awards without the affected Participant&#8217;s consent even if it does materially impair the Participant&#8217;s right if such amendment is done&#58; </font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(1)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">in a manner specified by the Plan, </font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(2)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">to maintain the qualified status of the Award as an Incentive Stock Option under Code Section&#160;422, </font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(3)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">to change the terms of an Incentive Stock Option, if such change results in impairment of the Award only because it impairs the qualified status of the Award as an Incentive Stock Option under Code Section&#160;422 or resets the Incentive Stock Option holding periods applicable to the Award, </font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(4)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">to clarify the manner of exemption from Code Section&#160;409A or compliance with any requirements necessary to avoid the imposition of additional tax or interest under Code Section&#160;409A(a)(1)(B), or </font></div><div style="margin-top:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(5)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt">to comply with other Applicable Laws. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Conditions Upon Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Legal Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Company will make good faith efforts to comply with all Applicable Laws related to the issuance of Shares. The Company will not issue Shares pursuant to an Award, including without limitation upon exercise or vesting thereof, as applicable, unless the issuance and delivery of such Shares and exercise or vesting of the Award, as applicable, will comply with Applicable Laws. If required by the Administrator, issuance will be further subject to the approval of counsel for the Company with respect to such compliance. If the Company determines it to be impossible or impractical to obtain authority from any regulatory body having jurisdiction or to complete or comply with the requirements of any Applicable Laws, registration or other qualification of the Shares under any state, federal or non-U.S. law or under the rules and regulations of the U.S. Securities and Exchange Commission, the stock exchange on which Shares of the same class are then listed, or any other governmental or regulatory body, which authority, registration, qualification or rule compliance is deemed by the Company&#8217;s counsel to be necessary or advisable for the issuance and sale of any Shares hereunder, the Company will be relieved of any liability regarding the failure to issue or sell such Shares as to which such authority, registration, qualification or rule compliance was not obtained and the Administrator reserves the authority, without the consent of a Participant, to terminate or cancel Awards with or without consideration in such a situation. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-indent:36pt"><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:23.77pt;text-decoration:underline">Investment Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. As a condition to the exercise or vesting of an Award, the Company may require the person exercising or vesting in such Award to represent and warrant during any such exercise or vesting that the Shares are being purchased only for investment and with no present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.</font></div><div style="margin-top:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:24.36pt;text-decoration:underline">Failure to Accept Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. If a Participant has not accepted an Award to the extent such acceptance has been requested or required by the Company or has not taken all administrative and other steps (e.g.,&#160;setting up an account with a broker designated by the Company) necessary for the Company to issue Shares upon the vesting, exercise, or settlement of the Award prior to the date that a portion of the Award is scheduled to vest, then the Award will be cancelled on such date and the Shares subject to the Award will revert to the Plan for no additional consideration unless otherwise provided by the Administrator. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:22.88pt;text-decoration:underline">Stockholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The Plan will be subject to approval by the stockholders of the Company within 12&#160;months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">22</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ibrx-20250618.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13d9eae9-a91a-4090-bf8c-9b7bc7debb08,g:5c9f2723-5c82-43d2-9f98-d449f80a92e6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ibrx="http://www.immunitybio.com/20250618" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.immunitybio.com/20250618">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ibrx-20250618_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ibrx-20250618_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.immunitybio.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ibrx-20250618_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13d9eae9-a91a-4090-bf8c-9b7bc7debb08,g:5c9f2723-5c82-43d2-9f98-d449f80a92e6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7cc85c05-b5f0-489c-96e3-7ef3190ebaf9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d6031d26-2ff3-481a-ab5c-9bf052173f7b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f64dfb11-c7a2-4709-9d96-f89afa83842b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_146dc8da-f413-42f1-ab7c-1f6512c231de_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5a532330-6d42-4dd0-952f-f817ed898cab_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_bd10b046-c284-48f9-8f07-54f02ab6cc27_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f255d106-06dd-4f40-94b5-21315fbec7d9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_70bf7114-5b69-484a-b941-652287b40a88_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c47d5bd1-6711-4614-977e-79a40e771729_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1414e45b-a1b6-42aa-9a00-065022e864e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b55de2eb-84df-46fc-9e39-af2977983817_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_fc4f257c-9751-4368-8bb9-8517b004e5dd_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1dfbd258-9351-4d2d-872d-c4c3a64c6855_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_101712f7-cc03-4e57-8a32-30502efe353b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security 12b Title</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_dd581068-17ee-44a3-979c-591483d64688_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0ebc75b3-a54d-4f91-bf96-6d236eb3462f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_474febdc-c663-43e7-8624-ba2501f157c8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1c6162f4-fea5-4124-a2c0-ba88d5d2ad34_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2119518a-10d9-4d43-b639-2acd98759cb9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c4f3edf9-0780-464e-b6cd-b1a43336f396_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_34c2f1f9-c075-4458-addb-792c4dca76c6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b064bb1e-0059-4d38-b251-6dc31dd4fecb_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_68da1c3c-28ed-452c-a659-f454a93219b7_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ibrx-20250618_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13d9eae9-a91a-4090-bf8c-9b7bc7debb08,g:5c9f2723-5c82-43d2-9f98-d449f80a92e6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.immunitybio.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="ibrx-20250618.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.immunitybio.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_efe483ad-899c-4c2b-ada3-cbeeb34c470f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_DocumentType_efe483ad-899c-4c2b-ada3-cbeeb34c470f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4b834c99-d646-4dd8-be2a-036b8d2cba81" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_DocumentPeriodEndDate_4b834c99-d646-4dd8-be2a-036b8d2cba81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_98e31aa8-316e-432e-821b-a56e1e6b2310" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityRegistrantName_98e31aa8-316e-432e-821b-a56e1e6b2310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7359f2a4-cb06-4e51-8888-a9c78fd8692b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7359f2a4-cb06-4e51-8888-a9c78fd8692b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_63395821-4a12-45f0-9914-3258dca50769" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityFileNumber_63395821-4a12-45f0-9914-3258dca50769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_566c6b67-8188-44e3-88d3-dfa5813617dd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityTaxIdentificationNumber_566c6b67-8188-44e3-88d3-dfa5813617dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_911aadd8-f1c2-49f1-9945-f8f3a239d842" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityAddressAddressLine1_911aadd8-f1c2-49f1-9945-f8f3a239d842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ddbb5d07-5d4a-477a-872b-a9b0ca15300a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityAddressCityOrTown_ddbb5d07-5d4a-477a-872b-a9b0ca15300a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_79dfbc7f-ad01-4282-a984-b883aae064be" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityAddressStateOrProvince_79dfbc7f-ad01-4282-a984-b883aae064be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c38fb34a-6314-44f4-a7c5-40e6a5ffa782" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityAddressPostalZipCode_c38fb34a-6314-44f4-a7c5-40e6a5ffa782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6646730b-be16-4faf-a575-763cdedc42dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_CityAreaCode_6646730b-be16-4faf-a575-763cdedc42dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b59171be-cc55-49e6-9781-02a54d51bfb2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_LocalPhoneNumber_b59171be-cc55-49e6-9781-02a54d51bfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5ec256f9-9a57-483a-b191-1b36cf051a01" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_WrittenCommunications_5ec256f9-9a57-483a-b191-1b36cf051a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7e2dc96a-9d63-4fa6-aeee-3dce164644bd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_SolicitingMaterial_7e2dc96a-9d63-4fa6-aeee-3dce164644bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_562f8c5b-6aac-4546-b18b-f75678f9f923" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_PreCommencementTenderOffer_562f8c5b-6aac-4546-b18b-f75678f9f923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_96eb19d9-ac99-41ef-a5b3-b903d1f7d7d1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_96eb19d9-ac99-41ef-a5b3-b903d1f7d7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_479b3831-a28e-4108-acec-eb22c79acbe1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_Security12bTitle_479b3831-a28e-4108-acec-eb22c79acbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5a87bec8-4c96-4333-91de-40db657f8b30" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_TradingSymbol_5a87bec8-4c96-4333-91de-40db657f8b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1d1458f9-915c-4f48-a582-d42d23508dc9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_SecurityExchangeName_1d1458f9-915c-4f48-a582-d42d23508dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e931cdd2-c786-42b1-9cf9-60208a3f9f9a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityEmergingGrowthCompany_e931cdd2-c786-42b1-9cf9-60208a3f9f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7cbf71d4-d28a-43a1-81da-dba830628894" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_AmendmentFlag_7cbf71d4-d28a-43a1-81da-dba830628894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cf824b35-39e5-4f9a-8951-f37900b41548" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8513de-3a7e-49a6-b132-3a0019abc060" xlink:to="loc_dei_EntityCentralIndexKey_cf824b35-39e5-4f9a-8951-f37900b41548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 18,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ImmunityBio, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">43-1979754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3530 John Hopkins Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(844)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">696-5235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IBRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ibrx-20250618.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.immunitybio.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="ibrx-20250618.htm">ibrx-20250618.htm</File>
    <File>ibrx-20250618.xsd</File>
    <File>ibrx-20250618_lab.xml</File>
    <File>ibrx-20250618_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ibrx-20250618.htm": {
   "nsprefix": "ibrx",
   "nsuri": "http://www.immunitybio.com/20250618",
   "dts": {
    "inline": {
     "local": [
      "ibrx-20250618.htm"
     ]
    },
    "schema": {
     "local": [
      "ibrx-20250618.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ibrx-20250618_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ibrx-20250618_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.immunitybio.com/role/DocumentandEntityInformation",
     "longName": "0000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ibrx-20250618.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ibrx-20250618.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation State Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security 12b Title",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001326110-25-000084-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001326110-25-000084-xbrl.zip
M4$L#!!0    ( .N$U%JVOC[PHA@  "W;   1    :6)R>"TR,#(U,#8Q."YH
M=&WM/6MWXCBRW^=7Z#)W=])[;.('+Y-N]J1)>H:93CHG9';FWB][A"V"-L9F
M9#N!^?5;)=F "01(=XB9T.=T-V!94I7JK5+I_3_'0Y_<,Q'Q,/CP@UDV?B L
M<$./![<??CCMMCN='_[9^N[]_^CZ[Q^O/Y.ST$V&+(A)6S :,X\\\'A X@$C
MOX7BCM]3<N73N!^*H:ZKU]KA:"+X[2 FEF%5LV;94]$T;<]AE#DZ=4RJ5PS'
MT'O]AJL[O7K/K7NLUS,:VFVSZCI]JV[9>M5M6'K%]BS=Z3L-W:M4G'[#H([%
M:IK79"8,XO7[-6J[E;II.3W3;3"[0:N]OF?5F!QW$ /, '<0-?GX0VD0QZ/F
M\?'#PT-YW!-^.12WQY9AVL<\\'G $.Z2:IYK^V#+EJ;C.,=C[+(T[3/6(^;F
M&L/W\FUX/]?E<2QH$"&F: RXQQ&KNM'0;3/KQV-\VH><6-8)/(#F5B5KB _Y
M*C@,A".*:>"R:7N8P]UJ6/#IM&G$ES6$;LWCWR\^=]T!&U)]<0# P/+I/ 6^
M9>B&I9M6ULFC2>:!PL<]&JDQFSX%>BVQ0/^U6VJ]'S#JM=X/64P)OJ^S/Q)^
M_Z'4#H,8:%>_F8S@-5=]^U"*V3@^E@MXW/KNN^_>QSSV68OWQ%A'DC5J9N/]
ML?KQ_;'JNA=ZD]9[C]^3*)[X[$/)X]'(IY-F$ 8,)L#'36S(A/K(/8\%\B,\
MOP0&$MQ5XX_C:];_4')U6/6 #K$GQINGP&(>LMDGG]Z6B,+2AQ*@M=GG8^;I
M?>HCY-S[4.KKEEEJ?3K]W#U_?YP;88L!SP. ;]*&$07U.X''QK^PR;1_J]0R
M8,%MJV::QJ-!CO,0"M9G D0(BY8L#"Y:,Y)$ ],@DM2:,2S'AU+$AR,?5U/^
M-A XR]P:E,>1!RLDQYL-DHX9A8F0WR0O-%-0)0 (:O8[DW!FW[B'W_N<"2+G
MQ):R;+OS2Q[^Q9=;V4_YWD> GM#+O@&#B/@,1&8+X=&-FHY4M?AL.DUO1=/L
M2?8]&^0X!W>&I"E6CN<(\AC(5M$N8H>ODYC_1NS-WDGI?<@#?<!0K(, +U='
M\<D#]^)!TS2,OY5DR];[:$2!)'H"UTQ]5MU,.VN]CVG/9UF?O5# !'4W]'TZ
MBE@S^W"2,9>2'KI\Z61(Q2U,HA?&<3ALX@Q B\7<I;Y.?7X;-!$1Z>/9Y,J&
MFF ,B(B];.3T<1D>'3_^W6F4'6/Y(Z-LRM^/97\B>YABIC**2_(=@ 01\*%D
MEQ: 3:=OCF(2A3[WR/<PP9/T81R.%I^,J(>JN6D0># =^5BB9-DR*21A1S"9
M$XD2A1T7B)6)DEJEK#G,,Q1-' C'Z@,Q@:09<G_2_.&&#X&C+]D#N0Z'-/A!
MBT!\@YH3O*\:1OQ/UC0;,(K\^J!04(=^Y*)EQ&(A^G^][-R<GY'NS>G->3=/
M''.3+\ILN^?M7Z\[-YWS+CF]/"/GO[=_.KW\\9RTOUQ<=+K=SI?+E2#DB=39
MR1)8&P'U&XT&0$AQ&&CDK-PN@W56K3@; F*M &3'[.R4&U:]\-S\=6Q;*Q#;
M?OIR?4$V-RHR7T&96\J6 &72T']Y;$,<R*Y89&<:!9)5('ZOSR]OR/7YU9?K
MFU?4%YM-]RH144+!1XY#TF4NNC?$M$DHB%D]\MZ1L$]NP&&&1XG@,8>!S\?N
M .QD1D[=&!^;CEU9QQ.%6R6T2W'RUVP4BI@<9=\9!<N413%A]Q@X$/(Q\]XU
MGR%*KJ2Y>ZZ,X+QCY,$O^A"Z&.!KND<G^@2&UEDP]6-*K9^3@/W]>[-FG)@-
M37U &_L@CXHNCW:B!JW*1H2^K5M]S6YYA.&.^!*>9-1HEUJ=X3 )H,%''FJD
M$[CEC>GPY7G>V @51^=C"B(+(496%U-("8U(-&(N.L@>X0'A<41 R 'GBW<'
M]GI5]MJ85$X%I_ZF!%)92B!D*Q+>[<HZ3KEN6MNNK&V6ZU7[R97=_/>J]32-
M[/^D*IOPP"J"SPC:&HV1I!]+@T>+'(YV+PG-RC.4 HC[4( E)*/?W1B,EW:8
M!+&8M$,O;]G@7@*&"&,V$N$]]C,S:2I@=C&?/E#!5NJ.V%N'WJF\>'.K\(G[
M#!KW0/JD&*UBK-?4[7K5J!]0^@R4WM!Q)PV-NY*X\_BME5H56S>=N@.RX4D$
M/U\V^*S_6/Q+!.[2A%H;4S&K:$%)WD?G,(P'3)#_@$\8>5QZC1O:24L)Z'6@
M 1N0SPNV!5/O11EGKU:]'0Z'/(KV<I%1:!+%U8?U7;&^G>LN.1^._'#"Q/ZM
M<%Z D\NPO&RABQ9,W,QEW5:?G7J>8%&4_O<9^C,S758OM>RJ;9"?PT% ?@I'
M=SR(")AQ(MX[1_Z96&G#QR_B)GR86J2-4JL+TS_C[#9<Q(*V1<0O-XS4D5_$
M%=B_7*:9;&@>.Z56&Y +K0-.%V?SW,E<A3":__]\I"SU=%_#*+4<R[3,XJS\
M9GLZ1RE4&+X9"< N'U&?L#%SDYC?8U0'Q "+--3K?H*RF?S)1X LCZV-X^PQ
M[R-AGPI&<VML KH:E<J[KZ"DSR$HKZM!&"RX':95:M6<FEZU[,VCT44AH5F
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MS6@T-,.JJ^_+A]#(R$_ (>+9:\D(P;$MS:XZ6JU>R;T\9^>F$C O]I9(T'A
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M#]'FJW%N'YV^VCZ3KO^3SM-7_P-02P,$%     @ ZX346NJ_GIZ[!@  *3$
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M!)5"CQ /OC#;CX()5Q^'BSD:#6\63T0\PPM'>_<WVI?VE_5'>W\#4$L#!!0
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M<7+V:- EN1[=BJ!95I(/JC\LUBJ[(B/K]SJO^,0I=V"+;:(<+;!D8>.'&_B
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M<<8PEJ7-#1?Z"G-:0N22)ES;@DE;N$V.R'_YL<3>Z-Y>9MJM<RQHK=*44G7
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M_-&P"FS>6&)>-I85'Q"Z&D+:GPV:G$S&E&2_3=A_->%/%K*1B'I=&E3G+CP
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M9@L"]'2%>\+!J8+^J3R2/<7>,XHU^.Y[.X5D6K&RJ632A!*?L%>VVGXG7C"
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ML?3NP0TY0$BHM;G>OY4/[R0]V&JV@REK 5!0@Q.<J$)OD.S>L!5S,$.BB/.
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MP,E<)*K8W54YT^%VP,MR<.:F0)AOYC'E>A'JSMO/=76C=5LQ&KT5$(:3N8)
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M<X+DI\=G1_/9T?7LZ"6C+>CNDS2SKB>B$)X]$84@9.$][J!%&'=8689<W+*
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M$C]1M3\M:F,$UB>704[R0!TA'.&+;[CVB\(;,,]F/WG46/><ZJ&S")/ 45F
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ME85>K?*B*IL9#RP5:&@0OV-,DTZ#I;OC<1B@(+92 UWJXBR]!:!/" Z?.L2
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M<G@M,C R-3 V,3@N>'-D4$L! A0#%     @ ZX346AQ%?T4V"@  =%4  !4
M             ( !=AL  &EB<G@M,C R-3 V,3A?;&%B+GAM;%!+ 0(4 Q0
M   ( .N$U%KJOYZ>NP8  "DQ   5              "  =\E  !I8G)X+3(P
M,C4P-C$X7W!R92YX;6Q02P$"% ,4    " #KA-1:J+"V!PQ=    *0, '@
M            @ '-+   :6)R>"TR,#(U-C(P>#AX:V5X:&EB:70Q,#$N:'1M
64$L%!@     %  4 4 $  !6*      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>ibrx-20250618_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ibrx-20250618.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001326110</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-06-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">ImmunityBio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37507</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">43-1979754</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3530 John Hopkins Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">(844)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">696-5235</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">IBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-23">2025-06-18</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
